Breathing and blood-flow testing in long-COVID symptoms
Part of Infections, Lungs & breathing clinical trials.
This trial studies how the lungs’ breathing (airflow) and blood flow may be off in people with long-COVID symptoms like tiredness, shortness of breath, or trouble exercising. It may help researchers understand what’s driving symptoms and what kinds of abnormalities could be targeted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You had a COVID-19 infection more than 3 months ago (or you are in the control group with no prior COVID-19)
- If you’re in the long-COVID group: you have new or worsening chronic fatigue, shortness of breath, or exercise intolerance since COVID-19 and the cause isn’t clear
- Your initial lung test (pulmonary function tests) is normal or only mildly abnormal
- You have no COVID-19 infection in the last 3 months and no breathing infection in the last 4 weeks
- You can consent and speak English; you are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a spa treatment program can help people with long COVID symptoms like fatigue, breathlessness, and brain fog. If you have had COVID-19 symptoms for more than 12 weeks and have two or more lingering issues, this may offer a drug-free way to feel better.
This study uses special imaging (PET/CT) to understand ongoing breathing problems or tiredness after COVID-19. It aims to learn how inflammation and changes in the body connect to symptoms that last more than 3 months.
This study looks at people with lingering post-COVID symptoms, especially breathing and lung-related findings, using home monitoring and medical tests. It may help researchers understand what’s driving ongoing symptoms and identify patterns that could guide better care.
This trial tests a program to help people with ongoing fatigue, shortness of breath, or chest pain after COVID-19. It uses a personalized plan to improve your daily function and heart health.
This study tests whether a structured breathing control technique can improve symptoms of long COVID. It may help by training how you breathe, but you must meet specific health and medication criteria to join.
This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.
Hear when a new Post-Acute COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.